from Helen Cui, Ph.D.
Company Name: Allgens Medical
Product Categories:
  • Medical
  • Distributor
  • Reseller
  • Sales Agent
Target Markets:
  • Worldwide
  • Africa
  • Central America
  • Middle East
  • South America

The Product

Bongold TM Mineralized Collagen Scaffold Bone Graft is a synthetic bi-phasic composite resembling the human cancellous bone in both composition and microstructure. The inorganic component, hydroxyapatite was embedded within a woven network of collagen fibers. The advanced bone graft is designed to boost healing followed by resorption and replacement by new bone growth.
The Bongold bone graft represents a new class of synthetic biomaterials designed for optimized handling during a procedure and increased responsiveness at the wound site. Together with superior moldability and excellent handling, Bongold graft’s composition and structure is designed to benefit the surgeon and patients during the course of bone recovery process. Bongold matrix is 80 percent porous, which helps to optimize delivery of bone marrow aspirate and other biologic factors crucial to the healing process.

The Opportunity

Allgens likes to team up with orthopedic companies to co-marketing or co-distribute products in China and in the US.

The Company

Allgens Medical, Inc is the US-based subsidiary of Allgens Medical Science and Technology Co, Ltd, based in Beijing, China. The parent company was founded in 2004 by a leading Chinese professor, Dr. Fuzhai Cui, from Tsinghua University, Beijing, China. His original research was awarded the highest national level technology advancement award from China in 2011 and 2012. Original funding for the company came through the Chinese government with the most recent funding round provided by a group of private equity investors whose goal is to introduce Allgens’ innovative synthetic biomimetic bone graft portfolio on the world stage.